click tracking
Swiss Life Sciences Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 101 - 120 out of 294 displayed.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15 »

FDA approves cobas Babesia, Roche’s first whole blood test for donor screening

Read more ››
By: Nasdaq / GlobenewsWire - 20 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Genkyotex Announces First Half 2019 Results

Read more ››
By: Nasdaq / GlobenewsWire - 19 Sep 2019
Related companies:  Genkyotex S.A.

AveXis presents new data at EPNS continuing to show significant therapeutic benefit of Zolgensma® in prolonging event-free survival now up to 5 years of age in patients with spinal muscular atrophy (SMA) Type 1

BASEL, Switzerland, Sept. 19, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 19 Sep 2019
Related companies:  Novartis International AG | Novartis Venture Fund | Novartis Pharma Schweiz AG | Novartis Pharma AG

Roche renews its commitment to the primary healthcare Phelophepa trains, marking the 25th anniversary

Read more ››
By: Nasdaq / GlobenewsWire - 19 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Sequana Medical Appoints Leading Experts as Heart Failure Scientific Advisors

Read more ››
By: Nasdaq / GlobenewsWire - 19 Sep 2019
Related companies:  Sequana Medical, Inc. | Sequana Medical NV | Sequana Medical NV

FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis

Read more ››
By: Nasdaq / GlobenewsWire - 18 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019

Read more ››
By: Nasdaq / GlobenewsWire - 17 Sep 2019
Related companies:  CRISPR Therapeutics AG

Nextech to Showcase Top Ranked Solutions at Plastic Surgery The Meeting 2019

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Nextech Invest AG

Novo Nordisk A/S – Share repurchase programme

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019

Sanofi: information concerning the total number of voting rights and shares, August 2019

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019

Roche ranked as one of the most sustainable healthcare companies in the Dow Jones Sustainability Indices for the eleventh year running

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Roche receives FDA clearance for cobas pro integrated solutions designed to help labs deliver faster results to patients

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Sanofi and Abbott partner to integrate glucose sensing and insulin delivery technologies to help change the way diabetes is managed

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019

Auris Medical Receives FDA and EMA Guidance for Keyzilen® Late-Stage Clinical Development Program

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019
Related companies:  Auris Medical AG

Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin showed non-inferiority when compared to intravenous formulations for people with HER2-positive breast cancer

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Strekin AG Announces Completion of Patient Recruitment in the RESTORE Phase 3 Clinical Study of STR001

BASEL, Switzerland, Sept. 12, 2019 /PRNewswire/ -- Strekin AG (www.strekin.com), a biopharmaceutical company focused on treatments for hearing loss, announced today that it has successfully completed patient recruitment in the RESTORE study, an international, randomized, placebo-controlled, Phase... Read more ››

By: PR Newswire Association LLC. - 12 Sep 2019
Related companies:  Strekin AG

Roche’s Tecentriq as a first-line monotherapy helped certain people with advanced non-small cell lung cancer live longer compared with chemotherapy

Read more ››
By: Nasdaq / GlobenewsWire - 12 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Roche’s satralizumab significantly reduced relapse risk in second positive phase III study for neuromyelitis optica spectrum

Read more ››
By: Nasdaq / GlobenewsWire - 12 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

ObsEva announces new composition of its Executive Committee

Read more ››
By: Nasdaq / GlobenewsWire - 11 Sep 2019
Related companies:  ObsEva SA
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15 »

Looking for companies outside of Switzerland?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • November 2019
    • Duesseldorf: DxPx Conference 2019
    • Krakow: Life Science Open Space 2019
  • December 2019
    • London: The Pharma Licensing Negotiation Course
See Events »
Add an Event »

Latest company news

CHMP recommends conditional EU approval of Roche’s Polivy for people with previously treated aggressive lymphoma
15 Nov 2019 (Nasdaq / GlobenewsWire)

CHMP recommends EU approval of Roche’s Kadcyla for the adjuvant treatment of people with HER2-positive early breast cancer with residual invasive disease after neoadjuvant treatment
15 Nov 2019 (Nasdaq / GlobenewsWire)

Trading in Novo Nordisk shares by board members, executives and associated persons on 14 November 2019
15 Nov 2019 (Nasdaq / GlobenewsWire)

Biotechgate database

About Biotechgate
The Swiss Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com